The Future of HIV-1 Therapeutics
Resistance Is Futile?
This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle…
Mehr
CHF 166.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
Weitere Autoren: Richman, Douglas D. (Hrsg.) / Torbett, Bruce E. (Hrsg.)
- ISBN: 978-3-319-37450-5
- EAN: 9783319374505
- Produktnummer: 21428658
- Verlag: Springer International Publishing
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 264 S.
- Masse: H23.5 cm x B15.5 cm x D1.4 cm 406 g
- Auflage: Softcover reprint of the original 1st ed. 2015
- Abbildungen: Paperback
- Gewicht: 406
2 weitere Werke von David S. (Hrsg.) Goodsell:
Bewertungen
Anmelden